LII vs RARE · P/E 27, rev $1.20B vs rev $350.0M
Lennox International Inc (LII) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Lennox International Inc (LII) is a building products & equipment company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported LII revenue for 2025-12-31 was $1.20B. Net income was $142.5M. Revenue was down 77.6% from 2024-12-31 to 2025-12-31. LII currently screens at market cap $21.44B and trailing P/E 26.9.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
LII currently screens at market cap $21.44B and trailing P/E 26.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the LII and RARE stock pages for the full models.
Not investment advice.